Search Results

You are looking at 1 - 2 of 2 items for :

  • glucocorticoid x
  • Top-cited articles of 2023 x
  • Refine by access: All content x
Clear All
Christina Antza Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Christina Antza in
Google Scholar
PubMed
Close
,
Georgios Kostopoulos Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece

Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed
Close
,
Samiul Mostafa Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Samiul Mostafa in
Google Scholar
PubMed
Close
,
Krishnarajah Nirantharakumar Institute of Applied Health Research, University of Birmingham, Birmingham, UK
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Krishnarajah Nirantharakumar in
Google Scholar
PubMed
Close
, and
Abd Tahrani Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Abd Tahrani in
Google Scholar
PubMed
Close

and hunger observed in people with habitual short sleep duration and/or forced sleep restriction. The impact of sleep on cortisol secretion is another plausible mechanism linking sleep duration to obesity and T2DM. Glucocorticoids secretion is

Open access
Robin Kristófi Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Robin Kristófi in
Google Scholar
PubMed
Close
and
Jan W Eriksson Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden

Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Close

inflammatory and autoimmune diseases. In a trial of patients receiving glucocorticoid treatment for various chronic inflammatory diseases, 12 weeks of treatment with metformin 2550 mg/day resulted in lower serum levels of high-sensitive CRP as compared to

Free access